Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.
Saved in:
| Title: | Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial. |
|---|---|
| Authors: | Ray-Coquard, I.1,2 (AUTHOR) isabelle.ray-coquard@lyon.unicancer.fr, Leary, A.2,3 (AUTHOR), Pignata, S.4,5 (AUTHOR), Cropet, C.2,6 (AUTHOR), González-Martín, A.7,8 (AUTHOR), Marth, C.9,10 (AUTHOR), Nagao, S.11,12 (AUTHOR), Vergote, I.13,14 (AUTHOR), Colombo, N.15,16 (AUTHOR), Mäenpää, J.17,18 (AUTHOR), Selle, F.2,19 (AUTHOR), Sehouli, J.20,21 (AUTHOR), Lorusso, D.5,22 (AUTHOR), Guerra Alia, E.M.8,23 (AUTHOR), Bogner, G.10,24 (AUTHOR), Yoshida, H.12,25 (AUTHOR), Lefeuvre-Plesse, C.2,26 (AUTHOR), Buderath, P.21,27 (AUTHOR), Mosconi, A.M.5,28 (AUTHOR), Lortholary, A.2,29 (AUTHOR) |
| Source: | Annals of Oncology. Aug2023, Vol. 34 Issue 8, p681-692. 12p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 164863153 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ray-Coquard%2C+I%2E%22">Ray-Coquard, I.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> isabelle.ray-coquard@lyon.unicancer.fr</i><br /><searchLink fieldCode="AR" term="%22Leary%2C+A%2E%22">Leary, A.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pignata%2C+S%2E%22">Pignata, S.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cropet%2C+C%2E%22">Cropet, C.</searchLink><relatesTo>2,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22González-Martín%2C+A%2E%22">González-Martín, A.</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marth%2C+C%2E%22">Marth, C.</searchLink><relatesTo>9,10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nagao%2C+S%2E%22">Nagao, S.</searchLink><relatesTo>11,12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vergote%2C+I%2E%22">Vergote, I.</searchLink><relatesTo>13,14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colombo%2C+N%2E%22">Colombo, N.</searchLink><relatesTo>15,16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mäenpää%2C+J%2E%22">Mäenpää, J.</searchLink><relatesTo>17,18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Selle%2C+F%2E%22">Selle, F.</searchLink><relatesTo>2,19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sehouli%2C+J%2E%22">Sehouli, J.</searchLink><relatesTo>20,21</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>5,22</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guerra+Alia%2C+E%2EM%2E%22">Guerra Alia, E.M.</searchLink><relatesTo>8,23</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bogner%2C+G%2E%22">Bogner, G.</searchLink><relatesTo>10,24</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yoshida%2C+H%2E%22">Yoshida, H.</searchLink><relatesTo>12,25</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lefeuvre-Plesse%2C+C%2E%22">Lefeuvre-Plesse, C.</searchLink><relatesTo>2,26</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buderath%2C+P%2E%22">Buderath, P.</searchLink><relatesTo>21,27</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mosconi%2C+A%2EM%2E%22">Mosconi, A.M.</searchLink><relatesTo>5,28</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lortholary%2C+A%2E%22">Lortholary, A.</searchLink><relatesTo>2,29</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Aug2023, Vol. 34 Issue 8, p681-692. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=164863153 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.05.005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 681 Titles: – TitleFull: Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ray-Coquard, I. – PersonEntity: Name: NameFull: Leary, A. – PersonEntity: Name: NameFull: Pignata, S. – PersonEntity: Name: NameFull: Cropet, C. – PersonEntity: Name: NameFull: González-Martín, A. – PersonEntity: Name: NameFull: Marth, C. – PersonEntity: Name: NameFull: Nagao, S. – PersonEntity: Name: NameFull: Vergote, I. – PersonEntity: Name: NameFull: Colombo, N. – PersonEntity: Name: NameFull: Mäenpää, J. – PersonEntity: Name: NameFull: Selle, F. – PersonEntity: Name: NameFull: Sehouli, J. – PersonEntity: Name: NameFull: Lorusso, D. – PersonEntity: Name: NameFull: Guerra Alia, E.M. – PersonEntity: Name: NameFull: Bogner, G. – PersonEntity: Name: NameFull: Yoshida, H. – PersonEntity: Name: NameFull: Lefeuvre-Plesse, C. – PersonEntity: Name: NameFull: Buderath, P. – PersonEntity: Name: NameFull: Mosconi, A.M. – PersonEntity: Name: NameFull: Lortholary, A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 – Type: issue Value: 8 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |